Table 4. Interaction between HIV and intensive care unit admission on in-hospital death among 907 persons with candidemia, adjusted for potential confounders, South Africa, 2012–2017*.

Variable	Stratum-specific aOR for death (95% CI)	Wald test p value†
Admitted to ICU
HIV-seronegative	Referent
HIV-seropositive	1.56 (1.00–2.43)	0.05
Not admitted to ICU
HIV-seronegative	Referent
HIV-seropositive	2.27 (1.47–3.52)	<0.001

*aOR, adjusted odds ratio; ICU, intensive care unit. 
†Overall likelihood ratio test for interaction p value = 0.22. Case-fatality ratio for those admitted to an ICU: HIV-seropositive (94/152; 62%), HIV-seronegative (157/301; 52%) versus those not admitted to an ICU: HIV-seropositive (117/224; 52%), HIV-seronegative (76/230; 33%).